BlackRock Japan’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-280
Closed -$30K 1402
2014
Q2
$30K Sell
280
-2,296
-89% -$225K ﹤0.01% 1112
2014
Q1
$224K Buy
+2,576
New +$199K ﹤0.01% 918
2013
Q3
Sell
-628
Closed -$21K 1474
2013
Q2
$21K Buy
+628
New +$22K ﹤0.01% 1209

BlackRock Japan's FURX Position: Q3 2014 in Review

BlackRock Japan sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 280 shares — an estimated $30K sold.

BlackRock Japan first reported a position in FURX in Q2 2013 and held it in 3 quarters. The position peaked at $224K in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • BlackRock Japan reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • BlackRock Japan sold 280 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $30K.
  • BlackRock Japan first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • BlackRock Japan's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $224K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.